New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For NYX;ICE;ELOQ;ORCL;ARRS;GOOG;RAD;KMX;FOLD;MDRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
November 17, 2014
16:01 EDTFOLDAmicus Therapeutics files to sell $75M in common stock
J.P. Morgan Securities LLC is acting as sole book-running manager for the proposed offering. Cowen and Company, LLC and Leerink Partners are acting as lead managers and Janney Montgomery Scott is acting as co-manager for the offering. The Company expects to use the net proceeds of the offering for investment in the global commercialization infrastructure for migalastat monotherapy for Fabry disease, the continued clinical development of its product candidates and for other general corporate purposes.
10:02 EDTKMXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:22 EDTFOLDOn The Fly: Pre-market Movers
Subscribe for More Information
06:23 EDTGOOGFacebook working on 'Facebook at Work' website, FT reports
Subscribe for More Information
06:10 EDTGOOGGoogle partners with Telstra to test Project Loon in Australia, SMH reports
Subscribe for More Information
05:35 EDTKMXCarMax downgraded to Equal Weight from Overweight at Morgan Stanley
Subscribe for More Information
November 16, 2014
14:53 EDTFOLDAmicus announces positive data from Fabry monotherapy study
Amicus Therapeutics announced additional positive data on important secondary endpoints from its second Phase 3 study of the oral small molecule chaperone migalastat HCl for Fabry disease. In a poster1 at the American Society of Nephrology Kidney Week 2014, results were presented from Fabry patients with amenable mutations in Study 012 who switched from standard of care enzyme replacement therapy, ERT, to migalastat as their only therapy for Fabry disease. Data from the Fabry Registry indicate that the leading cause of death in patients is from cardiac complications2. In Study 012, patients who switched from ERT to migalastat showed a statistically significant decrease from baseline to month 18 in left ventricular mass index-LVMi. LVMi is a measure of cardiac hypertrophy, an increase in the size of the heart that has been associated with an increased risk of cardiac events in Fabry patients."Cardiac disease represents a major cause of morbidity and mortality in Fabry patients that is not adequately addressed with currently available treatment," said Professor Ales Linhart, MD, PhD, a leading expert in the cardiac manifestations of Fabry disease from Charles University of Prague. "The data showing further regression of left ventricular mass in patients switched from ERT to migalastat in this study are very promising since in other cardiac conditions a reduction of cardiac mass typically translates to significant improvements in long term outcomes."
November 14, 2014
17:07 EDTGOOGSoros Fund Management gives quarterly update on stakes
Subscribe for More Information
06:12 EDTORCLSAP to pay Oracle $359M to settle legal battle, WSJ reports
Subscribe for More Information
06:00 EDTGOOGGoogle to retire Google Wallet for digital goods API on March 2, 2015
Subscribe for More Information
November 13, 2014
14:50 EDTRADLonestar Capital to shut down by mid-2015, WSJ reports
Subscribe for More Information
14:45 EDTRADLonestar capital to shut down, DJ reports
Subscribe for More Information
14:26 EDTGOOGAVG Technologies, Google renew Internet search and advertising agreement
AVG Technologies (AVG) announced earlier it has signed a renewal of its Internet search and advertising services agreement with Google (GOOG; GOOGL). The agreement has a 16-month term. AVG Technologies advised that the company's news release earlier today included an incorrect statement of the terms of the Google contract.
08:19 EDTMDRXAllscripts and MaineGeneral health Systems renew and expand relationship
Subscribe for More Information
07:12 EDTORCLOracle to hold a meeting
2014 OAGi Plenary Meeting is being held in Redwood City, California on November 13-14.
06:22 EDTGOOGLenovo, Asustek to launch $149 Chromebook, DigiTimes reports
Lenovo and Asustek plan to release Chromebooks using Google (GOOG) certified solutions from Rockchip in 1H15, reports DigiTimes. According to DigiTimes Resarch's latest finding from the Greater China supply chain, the devices are expected to be priced at $149. Reference Link
06:20 EDTGOOGAmazon's Web-services chief not threatened by cash threat from rivals, WSJ says
Subscribe for More Information
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use